Working… Menu
Trial record 69 of 385 for:    FERRIC CATION

Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency (CLEVER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01513369
Recruitment Status : Active, not recruiting
First Posted : January 20, 2012
Last Update Posted : October 9, 2019
Vifor Pharma
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : October 2018
Estimated Study Completion Date : October 2019